Article
A genetic variant in miRNA binding site of glutamate receptor 4, metabotropic (GRM4) is associated with increased risk of major depressive disorder.
Journal of affective disorders - 15 Jan 2017
Dadkhah Tahereh, Rahimi-Aliabadi Simin, Jamshidi Javad, Ghaedi Hamid, Taghavi Shaghyegh, Shokraeian Parasto, Akhavan-Niaki Haleh, Tafakhori Abbas, Ohadi Mina, Darvish Hossein
Abstract excerpt
BACKGROUND: Glutamate receptor 4, metabotropic (GRM4) expression is increased in the brain of patients with depression. The poorly conserved miR-1202 is downregulated in depression and is negatively correlated with GRM4. A variation located at the 3' UTR of the GRM4 gene may influence the interaction between miR-1202 and GRM4. The aim of this study was to determine the possible association between GRM4 3' UTR...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
